Literature DB >> 33692785

Glycocalyx as Possible Limiting Factor in COVID-19.

Patricia P Wadowski1, Bernd Jilma2, Christoph W Kopp1, Sebastian Ertl1,2, Thomas Gremmel1,3, Renate Koppensteiner1.   

Abstract

Entities:  

Keywords:  COVID-19; SARS-CoV-2; complement; glycocalyx; heparan sulfate

Mesh：

Substances：

Year:  2021        PMID： 33692785      PMCID： PMC7937603          DOI： 10.3389/fimmu.2021.607306

Source DB:  PubMed          Journal:  Front Immunol        ISSN： 1664-3224            Impact factor:   7.561


× No keyword cloud information.
  77 in total

Review 1.  The endothelial glycocalyx: composition, functions, and visualization.

Authors:  Sietze Reitsma; Dick W Slaaf; Hans Vink; Marc A M J van Zandvoort; Mirjam G A oude Egbrink
Journal:  Pflugers Arch       Date:  2007-01-26       Impact factor: 3.657

Review 2.  Endothelial cell dysfunction and glycocalyx - A vicious circle.

Authors:  Xiaohui Zhang; Dong Sun; Jeon W Song; Joseph Zullo; Mark Lipphardt; Leona Coneh-Gould; Michael S Goligorsky
Journal:  Matrix Biol       Date:  2018-02-01       Impact factor: 11.583

3.  Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells.

Authors:  Aleksandra Milewska; Miroslaw Zarebski; Paulina Nowak; Karol Stozek; Jan Potempa; Krzysztof Pyrc
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

4.  The effect of corticosteroid treatment on the cell surface glycocalyx of the rat pulmonary alveolus: relevance to the host-parasite relationship in pneumocystis carinii infection.

Authors:  K Yoneda; P D Walzer
Journal:  Br J Exp Pathol       Date:  1984-06

Review 5.  Biological Activities of Rhamnan Sulfate Extract from the Green Algae Monostroma nitidum (Hitoegusa).

Authors:  Koji Suzuki; Masahiro Terasawa
Journal:  Mar Drugs       Date:  2020-04-24       Impact factor: 5.118

6.  Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020.

Authors:  Kathy Leung; Marcus Hh Shum; Gabriel M Leung; Tommy Ty Lam; Joseph T Wu
Journal:  Euro Surveill       Date:  2021-01

7.  Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design.

Authors:  Christina L Gardner; Jozef Hritz; Chengqun Sun; Dana L Vanlandingham; Timothy Y Song; Elodie Ghedin; Stephen Higgs; William B Klimstra; Kate D Ryman
Journal:  PLoS Negl Trop Dis       Date:  2014-02-20

8.  Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3.

Authors:  Yao Wang; Julie K Pfeiffer
Journal:  MBio       Date:  2016-03-29       Impact factor: 7.867

9.  Decreased endothelial glycocalyx thickness is an early predictor of mortality in sepsis.

Authors:  Daniëlle Mh Beurskens; Martine E Bol; Tammo Delhaas; Marcel Cg van de Poll; Chris Pm Reutelingsperger; Gerry Af Nicolaes; Jan-Willem Em Sels
Journal:  Anaesth Intensive Care       Date:  2020-06-02       Impact factor: 1.669

10.  Increased Plasma Heparanase Activity in COVID-19 Patients.

Authors:  Baranca Buijsers; Cansu Yanginlar; Aline de Nooijer; Inge Grondman; Marissa L Maciej-Hulme; Inge Jonkman; Nico A F Janssen; Nils Rother; Mark de Graaf; Peter Pickkers; Matthijs Kox; Leo A B Joosten; Tom Nijenhuis; Mihai G Netea; Luuk Hilbrands; Frank L van de Veerdonk; Raphaël Duivenvoorden; Quirijn de Mast; Johan van der Vlag
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561
View more
  9 in total

Review 1.  Protection by metformin against severe Covid-19: An in-depth mechanistic analysis.

Authors:  Nicolas Wiernsperger; Abdallah Al-Salameh; Bertrand Cariou; Jean-Daniel Lalau
Journal:  Diabetes Metab       Date:  2022-05-31       Impact factor: 8.254

Review 2.  The Endothelial Glycocalyx: A Possible Therapeutic Target in Cardiovascular Disorders.

Authors:  Anastasia Milusev; Robert Rieben; Nicoletta Sorvillo
Journal:  Front Cardiovasc Med       Date:  2022-05-13

Review 3.  Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19.

Authors:  Duoduo Zha; Mingui Fu; Yisong Qian
Journal:  Cells       Date:  2022-06-19       Impact factor: 7.666

4.  Anti-Inflammatory Activity of Orally Administered Monostroma nitidum Rhamnan Sulfate against Lipopolysaccharide-Induced Damage to Mouse Organs and Vascular Endothelium.

Authors:  Masahiro Terasawa; Keiichi Hiramoto; Ryota Uchida; Koji Suzuki
Journal:  Mar Drugs       Date:  2022-02-03       Impact factor: 5.118

Review 5.  Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments.

Authors:  Niaz Mahmud; Muzahidul I Anik; M Khalid Hossain; Md Ishak Khan; Shihab Uddin; Md Ashrafuzzaman; Md Mushfiqur Rahaman
Journal:  ACS Appl Bio Mater       Date:  2022-05-18

6.  Molecular dynamics simulations of the delta and omicron SARS-CoV-2 spike - ACE2 complexes reveal distinct changes between both variants.

Authors:  Eileen Socher; Lukas Heger; Friedrich Paulsen; Friederike Zunke; Philipp Arnold
Journal:  Comput Struct Biotechnol J       Date:  2022-02-26       Impact factor: 7.271

Review 7.  Mineralocorticoid receptor-antagonism prevents COVID-19-dependent glycocalyx damage.

Authors:  Benedikt Fels; Sovon Acharya; Carl Vahldieck; Tobias Graf; Nadja Käding; Jan Rupp; Kristina Kusche-Vihrog
Journal:  Pflugers Arch       Date:  2022-07-22       Impact factor: 4.458

8.  Thromboprophylaxis in COVID-19 - Rationale and considerations.

Authors:  Sotirios Bristogiannis; Dawn Swan; Jecko Thachil
Journal:  Adv Biol Regul       Date:  2021-07-23

9.  Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure.

Authors:  Halie M Rando; Adam L MacLean; Alexandra J Lee; Ronan Lordan; Sandipan Ray; Vikas Bansal; Ashwin N Skelly; Elizabeth Sell; John J Dziak; Lamonica Shinholster; Lucy D'Agostino McGowan; Marouen Ben Guebila; Nils Wellhausen; Sergey Knyazev; Simina M Boca; Stephen Capone; Yanjun Qi; YoSon Park; David Mai; Yuchen Sun; Joel D Boerckel; Christian Brueffer; James Brian Byrd; Jeremy P Kamil; Jinhui Wang; Ryan Velazquez; Gregory L Szeto; John P Barton; Rishi Raj Goel; Serghei Mangul; Tiago Lubiana; Anthony Gitter; Casey S Greene
Journal:  mSystems       Date:  2021-10-26       Impact factor: 6.496
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.